{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:16:50Z","timestamp":1790813810727,"version":"4.1.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2018.00529","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T08:21:53Z","timestamp":1543306913000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Dorothy A.","family":"Fink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence M.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed","family":"Pyeritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai E.","family":"Elizur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00292","article-title":"FXPOI: pattern of AGG interruptions does not show an association with age at amenorrhea among women with a premutation.","volume":"9","author":"Allen","year":"2018","journal-title":"Front. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1093\/humrep\/dem148","article-title":"Examination of reproductive aging milestones among women who carry the FMR1 premutation.","volume":"228","author":"Allen","year":"2007","journal-title":"Hum. Reprod."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1007\/s12035-016-0194-7","article-title":"Impaired mitochondrial function and dynamics in the pathogenesis of FXTAS.","volume":"54","author":"Alvarez-Mora","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/jama.1993.03510130075034","article-title":"Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.","volume":"270","author":"Brown","year":"1993","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/humrep\/dev280","article-title":"Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.","volume":"311","author":"Buijsen","year":"2016","journal-title":"Hum. Reprod."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/humrep\/16.7.1527","article-title":"Ovarian and endometrial function during hormonal contraception.","volume":"167","year":"2001","journal-title":"Hum. Reprod."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1210\/jc.2015-4063","article-title":"Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomized controlled trial of the effects on bone mineral density.","volume":"1019","author":"Cartwright","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/j.1365-2559.2011.03959.x","article-title":"Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls histopathology.","author":"Chang","year":"2011"},{"key":"B9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2353\/jmoldx.2010.090227","article-title":"An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis.","volume":"12","author":"Chen","year":"2010","journal-title":"JMD"},{"key":"B10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ajhg.2009.09.007","article-title":"Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA.","volume":"85","author":"Coffee","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/molehr\/gaw023","article-title":"Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.","volume":"226","author":"Conca Dioguardi","year":"2016","journal-title":"Mol. Hum. Reprod."},{"key":"B12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems.","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpag.2010.12.004","article-title":"A family systems approach to primary ovarian insufficiency.","volume":"243","author":"Covington","year":"2011","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00125817-200109000-00006","article-title":"FMR1 and the fragile X syndrome: human genome epidemiology review.","volume":"3","author":"Crawford","year":"2001","journal-title":"Genet. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1086\/515496","article-title":"Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. collaborative fragile X study group.","volume":"61","author":"de Vries","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1196\/annals.1429.029","article-title":"Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency.","volume":"1135","author":"De Caro","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ng0994-88","article-title":"Length of uninterrupted CGG repeats determines instability in the FMR1 gene.","volume":"8","author":"Eichler","year":"1994","journal-title":"Nat. Genet."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105121","article-title":"Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers.","volume":"98","author":"Elizur","year":"2014","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.ejhg.5201510","article-title":"Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers.","volume":"142","author":"Ennis","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.gene.2007.02.026","article-title":"Regional FMRP deficits and large repeat expansions into the full mutation range in a new fragile X premutation mouse model.","volume":"395","author":"Entezam","year":"2007","journal-title":"Gene"},{"key":"B21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00210744","article-title":"Polymerase chain reaction analysis of fragile X mutations.","volume":"90","author":"Erster","year":"1992","journal-title":"Hum. Genet."},{"key":"B22","first-page":"245","article-title":"A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency.","volume":"564","author":"Falorni","year":"2014","journal-title":"Panminerva Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1373\/clinchem.2009.136101","article-title":"A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.","volume":"56","author":"Filipovic-Sadic","year":"2010","journal-title":"Clin. Chem."},{"key":"B24","year":"2018"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/0092-8674(91)90283-5","article-title":"Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.","volume":"67","author":"Fu","year":"1991","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1042\/BCJ20160585","article-title":"Plasma metabolic profile delineates roles for neurodegeneration, pro-inflammatory damage and mitochondrial dysfunction in the FMR1 premutation.","volume":"47321","author":"Giulivi","year":"2016","journal-title":"Biochem. J."},{"key":"B27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2753.1999.00209.x","article-title":"The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: a literature review.","volume":"5","author":"Greenhalgh","year":"1999","journal-title":"J. Eval. Clin. Pract."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.fertnstert.2004.11.067","article-title":"Assessing the emotional needs of women with spontaneous premature ovarian failure.","volume":"836","author":"Groff","year":"2005","journal-title":"Fertil. Steril."},{"key":"B29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1212\/WNL.57.1.127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.","volume":"571","author":"Hagerman","year":"2001","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/GIM.0b013e3181fa9fad","article-title":"FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor\/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States.","volume":"13","author":"Hantash","year":"2011","journal-title":"Genet. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/BOR.0000000000000257","article-title":"Improving care delivery and outcomes in pediatric rheumatic diseases.","volume":"282","author":"Harris","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1196\/annals.1429.018","article-title":"The menstrual cycle: basic biology.","volume":"1135","author":"Hawkins","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/GIM.0b013e3181e38fb6","article-title":"A systematic review of population screening for fragile X syndrome.","volume":"12","author":"Hill","year":"2010","journal-title":"Genet. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/GME.0000000000000658","article-title":"Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI).","volume":"239","author":"Hipp","year":"2016","journal-title":"Menopause"},{"key":"B35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1369\/0022155412441002","article-title":"Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency.","volume":"606","author":"Hoffman","year":"2012","journal-title":"J. Histochem. Cytochem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/ajmg.a.36511","article-title":"Epidemiology of fragile X syndrome: a systematic review and meta-analysis.","author":"Hunter","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"B37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/gepi.20329","article-title":"Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.","volume":"326","author":"Hunter","year":"2008","journal-title":"Genet. Epidemiol."},{"key":"B38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9378(71)90927-6","article-title":"Serum gonadotropin and steroid patterns during the normal menstrual cycle.","volume":"1111","author":"Mishell","year":"1971","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.fertnstert.2006.04.028","article-title":"Testosterone deficiency in young women with 46,XX spontaneous premature ovarian failure.","volume":"865","author":"Kalantaridou","year":"2006","journal-title":"Fertil. Steril."},{"key":"B40","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13311-014-0292-z","article-title":"Repeat-associated non-AUG translation and its impact in neurodegenerative disease.","volume":"114","author":"Kearse","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/HYPERTENSIONAHA.108.126516","article-title":"Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure.","volume":"535","author":"Langrish","year":"2009","journal-title":"Hypertension"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00244","article-title":"The role of AGG interruptions in fragile X repeat expansions: a twenty-year perspective.","volume":"5","author":"Latham","year":"2014","journal-title":"Front. Genet."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/gim","article-title":"CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve.","author":"Lekovich","year":"2017","journal-title":"Genet. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1093\/hmg\/dds348","article-title":"Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene.","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1093\/hmg\/dds348","article-title":"Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.","volume":"2123","author":"Lu","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.23736\/S0031-0808.16.03259-6","article-title":"A design thinking approach to primary ovarian insufficiency.","volume":"59","author":"Martin","year":"2017","journal-title":"Panminerva Med."},{"key":"B47","first-page":"1","article-title":"Mean age of mothers is on the rise: United States, 2000\u20132014.","author":"Mathews","year":"2016","journal-title":"NCHS Data Brief"},{"key":"B48","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/gim.2013.61","article-title":"ACMG standards and guidelines for fragile X testing: a revision to the disease-specific supplements to the standards and guidelines for clinical genetics laboratories of the american college of medical genetics and genomics.","volume":"15","author":"Monaghan","year":"2013","journal-title":"Genet. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-2000-13476","article-title":"Premature ovarian failure and the FMR1 gene.","volume":"18","author":"Murray","year":"2000","journal-title":"Semin. Reprod. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/humrep\/14.5.1217","article-title":"Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women.","volume":"14","author":"Murray","year":"1999","journal-title":"Hum. Reprod."},{"key":"B51","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1056\/NEJMcp0808697","article-title":"Clinical practice. Primary ovarian insufficiency.","volume":"3606","author":"Nelson","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.fertnstert.2004.11.059","article-title":"An update: spontaneous premature ovarian failure is not an early menopause.","volume":"835","author":"Nelson","year":"2005","journal-title":"Fertil. Steril."},{"key":"B53","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/pd.2815","article-title":"Fragile X analysis of 1112 prenatal samples from 1991 to 2010.","volume":"31","author":"Nolin","year":"2011","journal-title":"Prenat. Diagn."},{"key":"B54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/gim.2014.106","article-title":"Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers.","volume":"17","author":"Nolin","year":"2015","journal-title":"Genet. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ajmg.a.35833","article-title":"Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles.","volume":"161","author":"Nolin","year":"2013","journal-title":"Am. J. Med. Gen."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.252.5009.1097","article-title":"Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome.","volume":"252","author":"Oberl\u00e9","year":"1991","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/13697137.2010.507886","article-title":"Age of menopause and impact of climacteric symptoms by geographical region.","volume":"13","author":"Palacios","year":"2010","journal-title":"Climacteric"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00195","article-title":"The FMR1 gene, infertility, and reproductive decision-making: a review.","volume":"5","author":"Pastore","year":"2014","journal-title":"Front. Genet."},{"key":"B59","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrg1689","article-title":"Repeat instability: mechanisms of dynamic mutations.","volume":"6","author":"Pearson","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"B60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1006\/geno.2002.6849","article-title":"Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice.","volume":"80","author":"Peier","year":"2002","journal-title":"Genomics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1210\/jc.2013-4145","article-title":"Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement.","volume":"999","author":"Popat","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B62","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.fertnstert.2007.02.032","article-title":"Normalization of serum luteinizing hormone levels in women with 46,XX spontaneous primary ovarian insufficiency.","volume":"892","author":"Popat","year":"2008","journal-title":"Fertil. Steril."},{"key":"B63","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ogc.2012.09.007","article-title":"A new approach to primary ovarian insufficiency.","volume":"394","author":"Rafique","year":"2012","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"B64","doi-asserted-by":"publisher","first-page":"E278","DOI":"10.1210\/jc.2010-0613","article-title":"Depression in women with spontaneous 46, XX primary ovarian insufficiency.","volume":"962","author":"Schmidt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B65","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neuron.2016.12.016","article-title":"Translation of expanded CGG repeats into FMRpolyG is pathogenic and may contribute to fragile X tremor ataxia syndrome.","volume":"932","author":"Sellier","year":"2017","journal-title":"Neuron"},{"key":"B66","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ajmg.b.32065","article-title":"Prevalence of CGG expansions of the FMR1 gene in a US population-based sample.","author":"Seltzer","year":"2012","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J","article-title":"Premature ovarian failure in the fragile X syndrome.","volume":"973","author":"Sherman","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/1866-1955-6-26","article-title":"Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI).","volume":"61","author":"Sherman","year":"2014","journal-title":"J Neurodev. Disord."},{"key":"B69","author":"Sherman","year":"2007","journal-title":"FMR1 Premutation: A Leading Cause of Inherited Ovarian Dysfunction. In Fragile Sites: New Discoveries and Changing Perspectives."},{"key":"B70","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/GIM.0b013e31821705e5","article-title":"Predictors and risk model development for menopausal age in fragile X premutation carriers.","volume":"137","author":"Spath","year":"2011","journal-title":"Genet. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.contraception.2012.05.004","article-title":"Comparison of cervical mucus of 24\/4 vs. 21\/7 combined oral contraceptives.","volume":"866","author":"Steward","year":"2012","journal-title":"Contraception"},{"key":"B72","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.fertnstert.2008.07.007","article-title":"Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency.","volume":"922","author":"Streuli","year":"2009","journal-title":"Fertil. Steril."},{"key":"B73","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/humrep\/deh635","article-title":"Association of FMR1 repeat size with ovarian dysfunction.","volume":"202","author":"Sullivan","year":"2005","journal-title":"Hum. Reprod."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.fertnstert.2016.09.046","article-title":"Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.","volume":"1067","author":"Sullivan","year":"2016","journal-title":"Fertil. Steril."},{"key":"B75","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1055\/s-0031-1280915","article-title":"FMR1 and the continuum of primary ovarian insufficiency.","volume":"294","author":"Sullivan","year":"2011","journal-title":"Semin. Reprod. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2353\/jmoldx.2008.070073","article-title":"A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.","volume":"10","author":"Tassone","year":"2008","journal-title":"J. Mol. Diagn."},{"key":"B77","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/gme.0b013e3181647762","article-title":"Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.","volume":"155","author":"Tejada","year":"2008","journal-title":"Menopause"},{"key":"B78","first-page":"728","article-title":"The NAMS 2017 Hormone Therapy Position Statement Advisory Panel, 2017 hormone therapy position statement of The North American menopause society.","volume":"247","year":"2017","journal-title":"Menopause"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0851-1","article-title":"Using a meta-narrative literature review and focus groups with key stakeholders to identify perceived challenges and solutions for generating robust evidence on the effectiveness of treatments for rare diseases.","author":"Tingley","year":"2018","journal-title":"Orphanet"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-016-0296-x","article-title":"Quantifying growing versus non-growing ovarian follicles in the mouse.","volume":"10","author":"Uslu","year":"2017","journal-title":"J. Ovarian. Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/humupd\/5.5.483","article-title":"Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy.","volume":"5","author":"van Kasteren","year":"1999","journal-title":"Hum. Reprod. Update"},{"key":"B82","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0015-0282(16)57439-1","article-title":"The effect of three hormone replacement regimens on bone density in the aged ovariectomized rat.","volume":"633","author":"Vanin","year":"1995","journal-title":"Fertil. Steril."},{"key":"B83","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene FMR-1 containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"B84","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1210\/jc.2004-0347","article-title":"Evidence of early ovarian aging in fragile X premutation carriers.","volume":"899","author":"Welt","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/1866-1955-6-30","article-title":"Associated features in females with an FMR1 premutation.","volume":"61","author":"Wheeler","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165499","article-title":"Reactivation of FMR1 by CRISPR\/Cas9- mediated deletion of the expanded CGG-repeat of the fragile X chromosome.","volume":"11","author":"Xie","year":"2016","journal-title":"PLoS One"},{"key":"B87","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/gim.2012.34","article-title":"AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome.","volume":"14","author":"Yrigollen","year":"2012","journal-title":"Genet. Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/jhg.2013.50","article-title":"Transmission of an FMR1 premutation allele in a large family identified through newborn screening: the role of AGG interruptions.","volume":"58","author":"Yrigollen","year":"2013","journal-title":"J. Hum. Genet."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1126\/science.252.5009.1179","article-title":"Fragile X genotype characterized by an unstable region of DNA.","volume":"252","author":"Yu","year":"1991","journal-title":"Science"},{"key":"B90","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ajmg.a.30191","article-title":"Paternal transmission of fragile X syndrome.","author":"Zeesman","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"B91","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/humupd\/dmt0382","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.","volume":"201","author":"Zimmerman","year":"2014","journal-title":"Hum. Reprod. Update"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00529\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T19:35:34Z","timestamp":1662492934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00529\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":91,"alternative-id":["10.3389\/fgene.2018.00529"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2018.00529","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"article-number":"529"}}